05.02.2013 Views

Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle

Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle

Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2.9%<br />

R&D expenditure<br />

(% of GDP, 2004)<br />

Established cluster<br />

Switzerland<br />

3,436<br />

Researchers in<br />

R&D (per million<br />

people, 2003)<br />

Academic excellence, high-profile education programs and the high quality<br />

of life render Switzerland not only very competitive in the global market for<br />

life sciences talent, but increasingly at the entrepreneurial level too.<br />

Overview<br />

25.0%<br />

High technology<br />

exports (% overall<br />

exports, 2009)<br />

75 EMEA | <strong>Jones</strong> <strong>Lang</strong> <strong>LaSalle</strong><br />

11.3%<br />

Total health<br />

expenditure<br />

(% of GDP, 2009)<br />

Switzerland is one of Europe’s most established life sciences<br />

locations. For the second year running, Switzerland was<br />

rated number one in the World Economic Forum’s <strong>Global</strong><br />

Competitiveness <strong>Report</strong> 2010–<strong>2011</strong>, reflecting its advantages<br />

for the life science industry and other research, production and<br />

service companies. Switzerland is also a leader in education<br />

and is one of the world’s most active countries in research.<br />

The density of biotech companies in Switzerland is unparalleled<br />

world-wide. Its life sciences companies range from large<br />

multinational corporations such as Merck Serono, Novartis<br />

and Roche to innovative start-ups.<br />

The main clusters of life science activity can be found in Basel<br />

(BioValley), Zurich (Greater Zurich Area) and in Geneva (BioAlps).<br />

1<br />

World economic<br />

forum’s innovation<br />

rank (out of 142)<br />

There, the highly concentrated presence of the life sciences<br />

industry, universities and government assistance for spin-offs<br />

support the vibrant life sciences activities in these areas.<br />

Aided by the proximity of top pharmaceutical companies such as<br />

Roche and Novartis and by the strong financial sector in Zurich,<br />

academic excellence in the biomedical sciences serves as a<br />

motor for innovation in the biotech and medtech sector.<br />

Joint activities of universities and private companies provide<br />

favorable conditions for young start-up companies. Benefits such<br />

as low-cost rental space at the university’s labs during the first<br />

years and the availability of biotech parks and business incubators<br />

in and around Zurich also support life sciences growth.<br />

Tof C

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!